Tuesday, July 04, 2023 12:51:07 PM
Waiting for the SS INDEPENDENCE FROM PAIN and the SS BIEL to dock with the SS NO PAIN ACT and the SS AT ANY TIME.
Independence from Pain for the masses. Not an act either. But all about The Act, straight ahead.
No guarantees for BIEL, nor guaranteed to discount BIEL - that is - being unworthy of consideration by a partner/merger/buyout, as some firmly espouse, solely based on a specific past without regard to its accomplishments.
Accomplishments…not all inclusive…
Portable PEMF technology, 5 FDA clearances including musculoskeletal, no side-effects, distributors galore that a suitor can “straighten out” quickly, TURNKEY, backed by a Congress-passed Act with eyes on CMS insurance coverage, 11 Governors’ now backing earlier implementation of the ACT to January 2024.
Any prospective suitor that disregards BIEL’s above accomplishments because we have a low PPS, high OS, nil daily volume, nil sales, nil resources - instead of what the accomplishments mean to any suitors in terms of future income stream - is being beyond foolhardy imo.
>>>The beauty of the NOPAIN Act as the new BIEL pump is that it can't be proven wrong for a couple of years.<<<
Seems that only looking at BIEL’s past is the way to appraise BIEL’s future prospects by some. That logic is puzzling in that NOPAIN Act has never lived in BIEL’s past, so that crystal ball has a big chip in it. It is about now and the future only.
The NOPAIN Act, prospective suitors, and BIEL…
“It ain’t over until it’s over” ~ Yogi Berra
BIEL, still worth a reasonable investment.
Now
just in case
All imo.
Independence from Pain for the masses. Not an act either. But all about The Act, straight ahead.
No guarantees for BIEL, nor guaranteed to discount BIEL - that is - being unworthy of consideration by a partner/merger/buyout, as some firmly espouse, solely based on a specific past without regard to its accomplishments.
Accomplishments…not all inclusive…
Portable PEMF technology, 5 FDA clearances including musculoskeletal, no side-effects, distributors galore that a suitor can “straighten out” quickly, TURNKEY, backed by a Congress-passed Act with eyes on CMS insurance coverage, 11 Governors’ now backing earlier implementation of the ACT to January 2024.
Any prospective suitor that disregards BIEL’s above accomplishments because we have a low PPS, high OS, nil daily volume, nil sales, nil resources - instead of what the accomplishments mean to any suitors in terms of future income stream - is being beyond foolhardy imo.
>>>The beauty of the NOPAIN Act as the new BIEL pump is that it can't be proven wrong for a couple of years.<<<
Seems that only looking at BIEL’s past is the way to appraise BIEL’s future prospects by some. That logic is puzzling in that NOPAIN Act has never lived in BIEL’s past, so that crystal ball has a big chip in it. It is about now and the future only.
The NOPAIN Act, prospective suitors, and BIEL…
“It ain’t over until it’s over” ~ Yogi Berra
BIEL, still worth a reasonable investment.
Now
just in case
All imo.
